The following are important treatment considerations for you to discuss with your physician and understand in order to help avoid unsatisfactory results and complications.
- Patients who are using substances that can prolong bleeding, such as aspirin or ibuprofen, as with any injection, may experience increased bruising or bleeding at injection site. You should inform your physician before treatment if you are using these types of substances.
- If laser treatment, chemical peeling or any other procedure based on active dermal response is considered after treatment with JUVÉDERM Ultra Plus injectable gel, there is a possible risk of an inflammatory reaction at the treatment site.
- JUVÉDERM™ Ultra Plus injectable gel should be used with caution in patients on immunosuppressive therapy, or therapy used to decrease the body’s immune response, as there may be an increased risk of infection.
- The safety of JUVÉDERM™ Ultra Plus injectable gel for use during pregnancy, in breastfeeding females or in patients under 18 years has not been established.
- The safety of JUVÉDERM™ Ultra Plus injectable gel in patients with a history of excessive scarring (e.g. hypertrophic scarring and keloid formations) and pigmentation disorders has not been studied.
What Should My Physician Warn Me About?
The safety and effectiveness of JUVÉDERM™ Ultra Plus injectable gel for the treatment of areas other than facial wrinkles and folds (such as lips) have not been established in controlled clinical studies.
Learn about JUVÉDERM™, a “next generation” smooth gel dermal filler by visiting JUVÉDERM™ Injectable Gel Web Site